It is recommended to store this product at -20°C. The long term stability of this product at -80°C has not been determined. However, there are no issues anticipated by storing this material at ultra-low temperatures.
DPP4-M
DPP IV Inhibitor
Synonym(s):
DPP IV Inhibitor, Dipeptidyl peptidase 4 Inhibitor, Gliptins
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 1 mL | Check Cart for Availability | $79.40 | |
| 10 mL | Check Cart for Availability | $609.00 |
About This Item
UNSPSC Code:
41116012
NACRES:
NC.07
eCl@ss:
32160405
form
solution
Quality Level
NCBI accession no.
UniProt accession no.
Gene Information
human ... DPP4(1803)
General description
Dipeptidyl peptidase IV (DPP IV), a dimeric type II integral membrane glycoprotein, is a member of the family of prolyl-specific proteases. It is abundantly expressed in the epithelial and nonepithelial tissues. It is highly expressed in the kidney and the colon.[1]
Application
Research Category
All
All
Biochem/physiol Actions
Dipeptidyl peptidase IV (DPP IV) controls insulin-stimulating hormones, glucagon-like peptide (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP). It′s a promising therapeutic target for type 2 diabetes (T2DM).[2] In addition to its catalytic action, DPP-4 also serves as a binding protein and a ligand of extracellular factors.[3] DPP-4 inhibition causes GLP-1 and GIP to have a prolonged activity, hence DPP-4 inhibitors help maintain glucose homeostasis. DPP IV inhibitors can improve glycemic control for a longer period when compared to early oral hypoglycemics.[4]
Preparation Note
Upon arrival, store at 4°C. For long-term of more than 2 weeks, store at –20°C.
1 of 1
This Item | |||
|---|---|---|---|
| Gene Information human ... DPP4(1803) | Gene Information - | Gene Information - | Gene Information - |
| Quality Level 100 | Quality Level 200 | Quality Level 100 | Quality Level 100 |
| form solution | form solid | form amorphous solid | form solid |
| NCBI accession no. | NCBI accession no. - | NCBI accession no. - | NCBI accession no. - |
| UniProt accession no. | UniProt accession no. - | UniProt accession no. - | UniProt accession no. - |
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Sebastiano Bruno Solerte et al.
Acta diabetologica, 57(7), 779-783 (2020-06-09)
SARS-CoV-2 causes severe respiratory syndrome (COVID-19) with high mortality due to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein discussing a possible novel therapeutic tool for COVID-19. Virus binds to the cell surface receptor ACE2;
Rajesh Gupta et al.
Current drug targets, 10(1), 71-87 (2009-01-20)
Dipeptidyl peptidase IV (DPP IV) is a key regulator of insulin-stimulating hormones, glucagon-like peptide (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), thus it is a promising target for the treatment of Type 2 Diabetes mellitus (T2DM). Inhibition of plasma DPP IV
Sourav De et al.
Mini reviews in medicinal chemistry, 19(2), 88-97 (2018-04-26)
Diabetes mellitus is an emerging predator and affecting around 422 million adults worldwide. Higher levels of circulating insulin and increased pressure on the pancreas to produce insulin have been inferred as possible etiology for diabetes leading to a higher risk
Global Trade Item Number
| SKU | GTIN |
|---|---|
| DPP4-010 | 04053252366000 |
| DPP4 | 04053252362330 |
-
Would our lab be able to store this product at -80 degrees celsius without compromising its composition?
1 answer-
Helpful?
-
-
What is the concentration of this product and what is the working concentration suggested? Thanks!
1 answer-
This product as provided at a concentration of 4 mM. The working concentration recommendations are 10 μl/mL of whole blood or 20 μl/mL of buffer, plasma, serum, or tissue culture medium. These are general usage recommendations, the optimal concentration is application- and/or system-dependent. The final working concentration should be empirically determined by the end user.
Helpful?
-